(Q53764598)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

0 references

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Björn Schumacher

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Vipin Babu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Julienne K Muenzner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

G Lohmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

E Vasyutina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

J Bloehdorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

N Reinart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

J I Schneider

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

G Knittel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

G Crispatzu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

P Mayer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

C Prinz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

B Biersack

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

L Chessa

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

C D Herling

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

S Stilgenbauer

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

M Hallek

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

R Schobert

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

H C Reinhardt

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

M Herling

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

24 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

1177-1186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2016.294

26 March 2020

exact match

0 references

cites work

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Nucleotide excision repair in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Nucleotide Excision Repair and Transcription-coupled DNA Repair Abrogate the Impact of DNA Damage on Transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Age to survive: DNA damage and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Genome maintenance mechanisms for preventing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Cancer selective metallocenedicarboxylates of the fungal cytotoxin illudin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Melanoma-specific ferrocene esters of the fungal cytotoxin illudin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Anti-tumour compounds illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Influence of irofulven, a transcription-coupled repair-specific antitumor agent, on RNA polymerase activity, stability and dynamics in living mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

A C. elegans homolog of the Cockayne syndrome complementation group A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

DAF-16/FOXO and EGL-27/GATA promote developmental growth in response to persistent somatic DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Enhanced nucleotide excision repair in human fibroblasts pre-exposed to ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Trabectedin: Supportive care strategies and safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

inferred from DOI database lookup

7 January 2021

based on heuristic

Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.294

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2016.294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27773933%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference